Form 4: Health Catalyst Director Duncan Gallagher Acquires 2,001 Shares Through RSU Vesting
SEC Form 4
Health Catalyst director Duncan Gallagher acquired 2,001 shares of common stock through the vesting of restricted stock units.
Summary
- Director Duncan Gallagher of Health Catalyst, Inc. acquired 2,001 shares of common stock on December 1, 2024.
- The acquisition was a result of the vesting of restricted stock units (RSUs) granted under the company's 2019 Stock Option and Incentive Plan.
- Each RSU represents a contingent right to receive one share of Health Catalyst's common stock.
- The RSUs vested fully on December 1, 2024, in accordance with the company's Non-Employee Director Compensation Policy.
- Following the transaction, Gallagher's total direct holdings amount to 78,938 shares.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns interests. There are no indications of negative sentiment.
Positives
- The vesting of RSUs aligns director interests with shareholder value.
- The acquisition increases the director's stake in the company.
Industry Context
This is a standard transaction for a director of a public company, where equity compensation is a common practice to align interests with shareholders.
Comparison to Industry Standards
- Equity compensation through RSUs is a common practice for directors in publicly traded companies, such as those in the healthcare technology sector.
- Companies like Cerner (now Oracle Health) and Allscripts also use similar equity-based compensation plans for their directors.
- The vesting schedule and terms are generally aligned with industry norms to incentivize long-term value creation.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/01/2024 | Date of the RSU vesting and share acquisition. |
| 12/03/2024 | Date the Form 4 was signed. |
Keywords
Health Catalyst, Duncan Gallagher, restricted stock units, RSU, stock vesting, director, share acquisition, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.